Registry to track use of high-risk medical devices soon

NEW DELHI: Taking cue from the Johnson & Johnson faulty hip implants case which left patients in India in physical and financial distress, the health ministry is planning an independent registry to track use of medical devices considered to have a higher risk of complications or complaints.

Once the registry is in place, hospitals and doctors conducting surgeries involving high-end medical devices like orthopedic implants and stents will have to mandatorily report data related to the implant and its manufacturer along with side-effects and any adverse events reported by patients post-surgery.

If a significant number of concerns are reported with regard to a particular product, the regulator will evaluate the data and even order an immediate recall of the product if required. In case the effects are not very severe, the regulator can issue an alert or a warning on usage. These warnings can be on product packages or even in the form of advisories to hospitals and doctors.

The move follows recommendations of a government committee, under former dean of Maulana Azad Medical College Dr Arun K Agarwal, which examined complaints regarding replacement surgeries using the J&J hip implants. “Provisions may be introduced under the law for a legal backing for issuing alerts and warnings to the manufacturer,” the committee said in its report.

“This will not only help save many patients from suffering adverse fallouts but also help in providing a trend analysis of performance of various medical devices in India annually,” a senior official told TOI.

Such registeries are in place in most developed countries like US, European nations, Australia and Japan and have often helped regulators raise an alarm in case of faulty products without waiting for the manufacturer to withdraw the device or take action. In most countries, such registries are maintained by specialist associations while in others the drug regulator, government or research agencies are involved. There is no such mechanism in place for medical devices in India. “There is no authentic data on number of implants used or replacement surgeries conducted,” the official said.

  • Related Posts

    Pain is passé in Blood Test, thanks to Metropolis’ Human Touch

    New Delhi: Blood drawing for test has really reached proverbial ant bite, thanks to introduction of innovative blood collection technology by Metropolis healthcare, India’s second largest pathology laboratory chain. First…

    60 Countries witnessed AMTZ, Seed of Global Hub of Medical Devices

    Vishakhapatnam: It could be the beginning of the end of dependence of India on imports of medical devices. Import lobby must have watched this gathering of 60 countries to witness…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt